Abstract
Pyrexia is a protective physiologic response of the body against external and internal aggression. Temperature control is safe in and effective in septic shock but remain controversial in sepsis. Treating pyrexia to reduce oxygen consumption appears to have beneficial in cardiac arrest, low cardiac output and acute brain injury. Multiple therapeutic options are available for managing pyrexia, with precise targeted temperaturemanagement. Notably, the use of pharmacotherapy versus surface cooling has not been shown to be advantageous. When these two-therapy failed to control the extra-corporal method of cooling should be started. Renal replacement therapies are not typically indicated for temperature control but, in patients requiring renal support, they contribute to heat loss and participate in pyrexia control. Renal replacement therapies may represent a confounding factor in comparative trials on temperature control.
References
Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994;106:221- 235
Loke AY, Chan HC, Chan T. Comparing the effectiveness of two type of cooling blankets for febrile patients. Nurs Crit Care. 2005;10(5):247 54.
Circiumaru B, Baldock G, Cohen J. A prospective study of fever in the intensive care unit. Intensive Care Med. 1999;25(7):668-73.
Kirkness CJ, Burr RL, Thompson HJ, Mitchell PH. Temperature rhythm in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2008;8(3):380-90.
Gazendam JA, Van Dongen HP, Grant DA, Freedman NS, Zwaveling JH, Schwab RJ. Altered circadian rhythmicity in patients in the ICU. Chest. 2013;144(2):483-9
Young PJ, Saxena M. Fever management in intensive care patients with infections. Crit Care. 2014; 18: 206.
Manthous CAHJ, Olson D, Singh M, Chatila W, Pohlman A, Kushner R, Schmidt GA, Wood LD. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med. 1995;151(l):10-4.
Poblete B, Romand JA, Pichard C, Konig P, Suter PM. Metabolic effects of i.v. propacetamol, metamizol or external coolingin critically ill febrile sedated patients. Br J Anaesth. 1997;78(2): 123-7.
Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB. The effects of ibuprofen onthe physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med. 1997;336(13):912-8.
Badjatia N. Hyperthermia and fever control in brain injury. Crit Care Med. 2009;37(7 Suppl): S 250-7.
Niven DJ, Stelfox HT, Shahpori R, Laupland KB. Fever in adult ICUs: an interrupted time series analysis. Crit Care Med. 2013;41 (8): 1863-9.
Young PJ, Saxena M, Beasley R, Bellomo R, Bailey M, Pilcher D, Finfer S, Harrison D, Myburgh J, Rowan K. Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med. 2012;38(3):437^14.
Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, Tada K, Tanaka K, Ietsugu K,Uehara K, Dote K, Tajimi K, Morita K, Matsuo K, Hoshino K, Hosokawa K, Lee KH, Lee KM, Takatori M, Nishimura M, Sanui M, Ito M, Egi M, Honda N, Okayama N, Shime N, Tsuruta R, Nogami S, Yoon SH, Fujitani S, et al.
Broessner G, Beer R, Lackner P, Helbok R, Fischer M, Pfausler B, Rhorer J, Kuppers-TiedtL, Schneider D, Schmutzhard E. Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovasculardisease: bicenter prospective, randomized trial. Stroke. 2009;40(12): e 657- 65
Greer DM, Funk SE, Reaven NL, Ouzounelli M, Uman GC. Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke. 2008; 39 (11):3029-35.
Lantigua H, Ortega-Gutierrez S, Schmidt JM, Lee K, Badjatia N, Agarwal S, Claassen J, Connolly ES, Mayer SA. Subarachnoid hemorrhage: who dies, and why? Crit Care. 2015; 19: 309.
Mourvillier B, Tubach F, van de Beek D, Garot D, Pichon N, Georges H, Lefevre LM, BollaertPE, Boulain T, Luis D, Cariou A, Girardie P, Chelha R,
Megarbane B, Delahaye A, Chalumeau- Lemoine L, Legriel S, Beuret P, Brivet F, Bruel C, Camou F, Chatellier D, Chillet P, Clair B, Constantin JM, Duguet A, Galliot Bayle F,Hyvernat H, Ouchenir K, et al. Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA. 2013;310(20):2174-83.
Saxena M, Young P, Pilcher D, Bailey M, Harrison D, Bellomo R, Finfer S, Beasley R, Hyam J, Menon D, Rowan K, Myburgh J. Early temperature and mortality in critically ill patients with acute neurological diseases:trauma and stroke differ from infection. Intensive Care Med. 2015;41(5):823-32.
Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, Brun-Buisson C, Lemaire F, Brochard L. Fever control using externalcooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med. 2012; 185(10): 1088-95.
Young P, Saxena M, Bellomo R, Freebairn R, Hammond N, van Haren F, Holliday M, Henderson S, Mackle D, McArthur C, McGuinness S, Myburgh J, Weatherall M, Webb S, Beasley R. Acetaminophen for fever in critically ill patients with suspected infection. N Engl J Med. 2015;373(23):2215-24.
Hammond NE, Boyle M. Pharmacological versus non-pharmacological antipyretic treatments in febrile critically ill adult patients:a systematic review and meta-analysis. Aust Crit Care. 2011;24(1):4-17.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.